Tema Oncology ETF (NASDAQ:CANC) Sees Large Increase in Short Interest

Tema Oncology ETF (NASDAQ:CANC) saw a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 2,200 shares, an increase of 175.0% from the November 15th total of 800 shares. Based on an average daily trading volume, of 2,800 shares, the days-to-cover ratio is currently 0.8 days.

Tema Oncology ETF Price Performance

Shares of CANC stock traded down $0.51 during mid-day trading on Friday, hitting $25.04. The stock had a trading volume of 4,460 shares, compared to its average volume of 6,521. Tema Oncology ETF has a fifty-two week low of $24.94 and a fifty-two week high of $30.11. The company’s 50-day simple moving average is $27.66 and its 200-day simple moving average is $28.09. The firm has a market cap of $43.57 million, a PE ratio of 26.86 and a beta of 1.11.

Tema Oncology ETF Announces Dividend

The firm also recently declared a dividend, which was paid on Thursday, December 12th. Stockholders of record on Wednesday, December 11th were issued a $0.7283 dividend. The ex-dividend date of this dividend was Wednesday, December 11th.

Institutional Trading of Tema Oncology ETF

An institutional investor recently bought a new position in Tema Oncology ETF stock. Thrivent Financial for Lutherans purchased a new position in shares of Tema Oncology ETF (NASDAQ:CANC) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 319,376 shares of the company’s stock, valued at approximately $8,616,000. Thrivent Financial for Lutherans owned 19.01% of Tema Oncology ETF as of its most recent SEC filing.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.